北海康成製藥有限公司（股票代码：01228）于2026年5月6日发布截至2026年4月30日的股份变动月报。报告显示，公司本月股本维持稳定，具体情况如下：
北海康成製藥有限公司目前注册股本为5,000,000,000股普通股，每股面值为USD0.00001，注册股本总额USD50,000。截至4月30日，已发行股份总数为595,443,347股，与上月底持平；库存股份数量为0股。期间不存在新增发行、购回或注销情况。
期权与激励方面，截至本月末，首次公开发售后购股权计划中有1,000股期权在月内失效，剩余14,127,700份期权并未新增发行股份；首次公开发售前股权激励计划可发行或转让20,695,760股，首次公开发售后受限制股份单位计划暂未涉及新增可发行股份。
公司表示，已符合香港联交所相关规则要求，并确认公司持股量满足公众持股比例。公告由董事长薛群博士签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.